Default: Biology of Blood and Marrow Transplantation

ISSN: 1083-8791

Journal Home

Journal Guideline

Biology of Blood and Marrow Transplantation Q1 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Biology of Blood and Marrow Transplantation is a journal indexed in SJR in Hematology and Transplantation with an H index of 120. It has a price of 1260 €. It has an SJR impact factor of 2,301 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,301.

Biology of Blood and Marrow Transplantation focuses its scope in these topics and keywords: transplantation, cell, patients, hematopoietic, stem, allogeneic, graftversushost, cd, treatment, multiple, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

1260 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Biology of Blood and Marrow Transplantation

2,301

SJR Impact factor

120

H Index

409

Total Docs (Last Year)

1086

Total Docs (3 years)

14881

Total Refs

4502

Total Cites (3 years)

978

Citable Docs (3 years)

4,16

Cites/Doc (2 years)

36,38

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


transplantation, cell, patients, hematopoietic, stem, allogeneic, graftversushost, cd, treatment, multiple, longterm, leukemia, positive, risk, time, lymphoblastic, relapse, hla, chemotherapybased, centershaploidentical, cells, causing, bone,



Best articles by citations

Effective purging of autologous hematopoietic stem cells using anti-B-cell monoclonal antibody-coated high-density microparticles prior to high-dose therapy for patients with non-Hodgkin's lymphoma

View more

Administration of daniplestim and granulocyte colony-stimulating factor for the mobilization of hematopoietic progenitor cells in nonhuman primates

View more

Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experience

View more

Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease

View more

"Pet Negativity" - The New Goal of Cytoreductive Therapy in Hodgkin's Lymphoma?

View more

Autologous stem cell transplantation for small cell lung cancer

View more

Ex vivo expansion of immature 4-hydroperoxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood

View more

An Assay for Human Hematopoietic Stem Cells Based on Transplantation into Nonobese Diabetic Recombination Activating Gene-Null Perforin-Null Mice

View more

Autologous versus allogeneic unrelated donor transplantation for acute lymphoblastic leukemia: Comparative toxicity and outcomes

View more

Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma

View more

Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study

View more

"Nonmyeloablative regimen preserves ""niches"" allowing for peripheral expansion of donor T-cells"

View more
SHOW MORE ARTICLES

Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantation

View more

Evaluation and Automation of Hematopoietic Chimerism Analysis Based on Real-Time Quantitative Polymerase Chain Reaction

View more

The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: An analysis of sequential phase I/II trials from the Dana-

View more

Intravenous immunoglobulin: Appropriate indications and uses in hematopoietic stem cell transplantation

View more

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma

View more

Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation

View more

Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation

View more

Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: Low-dose TBI does not prevent sensitization

View more

Efficacy and safety of monoclonal anti-CD20 antibody (rituximab) for the treatment of patients with recurrent low-grade non-Hodgkin's lymphoma after high-dose chemotherapy and autologous hematopoietic cell transplantation

View more

Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants

View more

Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

View more

Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen

View more

FAQS